Cargando…
Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
Loss of huntingtin-mediated BDNF gene transcription has been shown to occur in HD and thus contribute to the degeneration of the striatum. Several studies have indicated that an increase in BDNF levels is associated with neuroprotection and amelioration of neurological signs in animal models of HD....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659095/ https://www.ncbi.nlm.nih.gov/pubmed/23700454 http://dx.doi.org/10.1371/journal.pone.0064037 |
_version_ | 1782270399104417792 |
---|---|
author | Giampà, Carmela Montagna, Elena Dato, Clemente Melone, Mariarosa A. B. Bernardi, Giorgio Fusco, Francesca Romana |
author_facet | Giampà, Carmela Montagna, Elena Dato, Clemente Melone, Mariarosa A. B. Bernardi, Giorgio Fusco, Francesca Romana |
author_sort | Giampà, Carmela |
collection | PubMed |
description | Loss of huntingtin-mediated BDNF gene transcription has been shown to occur in HD and thus contribute to the degeneration of the striatum. Several studies have indicated that an increase in BDNF levels is associated with neuroprotection and amelioration of neurological signs in animal models of HD. In a recent study, an increase in BDNF mRNA and protein levels was recorded in mice administered recombinant BDNF peripherally. Chronic, indwelling osmotic mini-pumps containing either recombinant BDNF or saline were surgically placed in R6/2 or wild-type mice from 4 weeks of age until euthanasia. Neurological evaluation (paw clasping, rotarod performance, locomotor activity in an open field) was performed. After transcardial perfusion, histological and immunohistochemical studies were performed. We found that BDNF- treated R6/2 mice survived longer and displayed less severe signs of neurological dysfunction than the vehicle treated ones. Primary outcome measures such as brain volume, striatal atrophy, size and morphology of striatal neurons, neuronal intranuclear inclusions and microglial reaction confirmed a neuroprotective effect of the compound. BDNF was effective in increasing significantly the levels of activated CREB and of BDNF the striatal spiny neurons. Moreover, systemically administered BDNF increased the synthesis of BDNF as demonstrated by RT-PCR, and this might account for the beneficial effects observed in this model. |
format | Online Article Text |
id | pubmed-3659095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36590952013-05-22 Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease Giampà, Carmela Montagna, Elena Dato, Clemente Melone, Mariarosa A. B. Bernardi, Giorgio Fusco, Francesca Romana PLoS One Research Article Loss of huntingtin-mediated BDNF gene transcription has been shown to occur in HD and thus contribute to the degeneration of the striatum. Several studies have indicated that an increase in BDNF levels is associated with neuroprotection and amelioration of neurological signs in animal models of HD. In a recent study, an increase in BDNF mRNA and protein levels was recorded in mice administered recombinant BDNF peripherally. Chronic, indwelling osmotic mini-pumps containing either recombinant BDNF or saline were surgically placed in R6/2 or wild-type mice from 4 weeks of age until euthanasia. Neurological evaluation (paw clasping, rotarod performance, locomotor activity in an open field) was performed. After transcardial perfusion, histological and immunohistochemical studies were performed. We found that BDNF- treated R6/2 mice survived longer and displayed less severe signs of neurological dysfunction than the vehicle treated ones. Primary outcome measures such as brain volume, striatal atrophy, size and morphology of striatal neurons, neuronal intranuclear inclusions and microglial reaction confirmed a neuroprotective effect of the compound. BDNF was effective in increasing significantly the levels of activated CREB and of BDNF the striatal spiny neurons. Moreover, systemically administered BDNF increased the synthesis of BDNF as demonstrated by RT-PCR, and this might account for the beneficial effects observed in this model. Public Library of Science 2013-05-20 /pmc/articles/PMC3659095/ /pubmed/23700454 http://dx.doi.org/10.1371/journal.pone.0064037 Text en © 2013 Giampà et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Giampà, Carmela Montagna, Elena Dato, Clemente Melone, Mariarosa A. B. Bernardi, Giorgio Fusco, Francesca Romana Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease |
title | Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease |
title_full | Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease |
title_fullStr | Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease |
title_full_unstemmed | Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease |
title_short | Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease |
title_sort | systemic delivery of recombinant brain derived neurotrophic factor (bdnf) in the r6/2 mouse model of huntington’s disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659095/ https://www.ncbi.nlm.nih.gov/pubmed/23700454 http://dx.doi.org/10.1371/journal.pone.0064037 |
work_keys_str_mv | AT giampacarmela systemicdeliveryofrecombinantbrainderivedneurotrophicfactorbdnfinther62mousemodelofhuntingtonsdisease AT montagnaelena systemicdeliveryofrecombinantbrainderivedneurotrophicfactorbdnfinther62mousemodelofhuntingtonsdisease AT datoclemente systemicdeliveryofrecombinantbrainderivedneurotrophicfactorbdnfinther62mousemodelofhuntingtonsdisease AT melonemariarosaab systemicdeliveryofrecombinantbrainderivedneurotrophicfactorbdnfinther62mousemodelofhuntingtonsdisease AT bernardigiorgio systemicdeliveryofrecombinantbrainderivedneurotrophicfactorbdnfinther62mousemodelofhuntingtonsdisease AT fuscofrancescaromana systemicdeliveryofrecombinantbrainderivedneurotrophicfactorbdnfinther62mousemodelofhuntingtonsdisease |